Cooley advised Decibel Bio, a plant biotechnology company building the world’s first crop epigenetic platform, on its $12 million financing round. The funding will be used to advance Decibel’s proprietary platform for both reading and writing the plant epigenome to create crop varieties with higher yield, efficiency and resilience to a changing environment.
Cooley advised Atalan Tech, a women-led, mission-driven company at the forefront of artificial intelligence technology for predicting and preventing clinician burnout and turnover in healthcare systems, on its $2.5 million seed financing.
Apollo Endosurgery to Be Acquired by Boston Scientific
February 1, 2023
Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.
